Volume 22, Number 10—October 2016
Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
|Patient no.||Age, mo, at VAPP onset/sex||No. doses OPV||Duration, mo, from last OPV dose to VAPP onset||Duration from VAPP onset to death†||Site of paralysis|
|2||7.5/M||4||1.1||4 mo||Left leg, right leg, right arm, respiratory muscles|
|3||10.6/M||4||3.3||1 mo||Left leg, right leg, right arm|
|4||15.1/M||4||9||11 mo||Left leg, right leg|
|5||5.3/F||2||3.2||<1 mo||Left leg, right leg|
|7||6.2/M||3||2||28 mo||Right leg|
|8||15.7/M||4||9.2||Alive||Left leg, right leg, left arm|
|9||25.2/M||4||6.7||<1 mo||Left leg|
|10||6.6/M||1||6.6||2 mo||Left leg, right leg|
|12||13.1/M||2||7||18 d||Not available|
|13||10.0/M||4||3||Alive||Left leg, right leg, left arm|
|14||9.0/M||4||2.8||Alive||Left leg, right leg|
*iVDPV, immunodeficiency-associated vaccine-derived poliovirus; NA, not applicable (patient 1 did not receive any OPV): OPV, oral poliovirus vaccine; VAPP, vaccine-associated paralytic poliomyelitis.
†Five patients were alive at the most recent follow-up. In March 2015, patient 6 was 9.5 years old, patient 8 was 5 years old, patient 11 was 3.5 years old, and patients 13 and 14 were 1.5 years old.
1These authors contributed equally to this article.